Allovirinc Stock Z Score
| ALVR Stock | USD 0.76 0.03 4.11% |
AllovirInc | Z Score |
AllovirInc Company Z Score Analysis
AllovirInc's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
| |||||||
| |||||||
| |||||||
| |||||||
|
AllovirInc Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for AllovirInc is extremely important. It helps to project a fair market value of AllovirInc Stock properly, considering its historical fundamentals such as Z Score. Since AllovirInc's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of AllovirInc's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of AllovirInc's interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
| Competition |
In accordance with the company's disclosures, AllovirInc has a Z Score of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.
AllovirInc Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AllovirInc's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AllovirInc could also be used in its relative valuation, which is a method of valuing AllovirInc by comparing valuation metrics of similar companies.AllovirInc is currently under evaluation in z score category among related companies.
AllovirInc Current Valuation Drivers
We derive many important indicators used in calculating different scores of AllovirInc from analyzing AllovirInc's financial statements. These drivers represent accounts that assess AllovirInc's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of AllovirInc's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.7B | 1.0B | 812.4M | 393.2M | 70.7M | 67.2M | |
| Enterprise Value | 1.6B | 920.0M | 640.8M | 322.5M | 8.0M | 7.6M |
AllovirInc Institutional Holders
Institutional Holdings refers to the ownership stake in AllovirInc that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of AllovirInc's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing AllovirInc's value.| Shares | Goldman Sachs Group Inc | 2023-12-31 | 932.1 K | Renaissance Technologies Corp | 2023-12-31 | 762 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 512.5 K | Charles Schwab Investment Management Inc | 2023-12-31 | 475.8 K | Northern Trust Corp | 2023-12-31 | 429.2 K | Jpmorgan Chase & Co | 2023-12-31 | 364.9 K | Marshall Wace Asset Management Ltd | 2023-12-31 | 324.7 K | Squarepoint Ops Llc | 2023-12-31 | 285.1 K | Two Sigma Investments Llc | 2023-12-31 | 264.6 K | Artal Group S A | 2023-12-31 | 6.6 M | Fmr Inc | 2023-12-31 | 5.7 M |
AllovirInc Fundamentals
| Return On Equity | -1.03 | ||||
| Return On Asset | -0.48 | ||||
| Current Valuation | (73.24 M) | ||||
| Shares Outstanding | 114.87 M | ||||
| Shares Owned By Insiders | 48.95 % | ||||
| Shares Owned By Institutions | 46.25 % | ||||
| Number Of Shares Shorted | 6.3 M | ||||
| Price To Book | 0.60 X | ||||
| Gross Profit | 165 K | ||||
| EBITDA | (180.93 M) | ||||
| Net Income | (190.42 M) | ||||
| Cash And Equivalents | 172.67 M | ||||
| Cash Per Share | 1.91 X | ||||
| Total Debt | 27.43 M | ||||
| Debt To Equity | 0.14 % | ||||
| Current Ratio | 8.18 X | ||||
| Book Value Per Share | 1.31 X | ||||
| Cash Flow From Operations | (124.45 M) | ||||
| Short Ratio | 12.99 X | ||||
| Earnings Per Share | (1.83) X | ||||
| Price To Earnings To Growth | (0.06) X | ||||
| Target Price | 1.0 | ||||
| Number Of Employees | 112 | ||||
| Beta | 0.85 | ||||
| Market Capitalization | 85.7 M | ||||
| Total Asset | 190.8 M | ||||
| Retained Earnings | (656.19 M) | ||||
| Working Capital | 159.27 M | ||||
| Current Asset | 61.62 M | ||||
| Current Liabilities | 53.23 M | ||||
| Net Asset | 190.8 M |
About AllovirInc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AllovirInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AllovirInc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AllovirInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AllovirInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AllovirInc's short interest history, or implied volatility extrapolated from AllovirInc options trading.
Pair Trading with AllovirInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AllovirInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AllovirInc will appreciate offsetting losses from the drop in the long position's value.Moving together with AllovirInc Stock
| 0.62 | ERAS | Erasca Inc Financial Report 20th of May 2024 | PairCorr |
Moving against AllovirInc Stock
| 0.69 | BIIB | Biogen Inc Earnings Call This Week | PairCorr |
| 0.62 | AMGN | Amgen Inc Financial Report 25th of April 2024 | PairCorr |
| 0.55 | VRTX | Vertex Pharmaceuticals Financial Report 6th of May 2024 | PairCorr |
The ability to find closely correlated positions to AllovirInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AllovirInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AllovirInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AllovirInc to buy it.
The correlation of AllovirInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AllovirInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AllovirInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AllovirInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out AllovirInc Piotroski F Score and AllovirInc Valuation analysis. To learn how to invest in AllovirInc Stock, please use our How to Invest in AllovirInc guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for AllovirInc Stock analysis
When running AllovirInc's price analysis, check to measure AllovirInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AllovirInc is operating at the current time. Most of AllovirInc's value examination focuses on studying past and present price action to predict the probability of AllovirInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AllovirInc's price. Additionally, you may evaluate how the addition of AllovirInc to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |
Is AllovirInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AllovirInc. If investors know AllovirInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AllovirInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.83) | Return On Assets (0.48) | Return On Equity (1.03) |
The market value of AllovirInc is measured differently than its book value, which is the value of AllovirInc that is recorded on the company's balance sheet. Investors also form their own opinion of AllovirInc's value that differs from its market value or its book value, called intrinsic value, which is AllovirInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AllovirInc's market value can be influenced by many factors that don't directly affect AllovirInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AllovirInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if AllovirInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AllovirInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.